Annika Nelde

University Hospital Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Yacine Maringer

University of Tuebingen

GERMANY

View details

Susanne Rittig

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jens Bauer

Postdoc – Head of Research

Universitätsklinikum Tübingen

GERMANY

View details

Natalie Köhler

Junior Professor

University Medical Center Freiburg

GERMANY

View details

Juliane S. Walz

University Hospital Tübingen

GERMANY

View details

Philip Bucher

University of Tübingen

GERMANY

View details

Helmut R. Salih

University Hospital Tübingen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Annika Nelde

Research Interests

Explore related searches

Contact this professor

Articles (10)

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Collaborators (7)

Yacine Maringer

Susanne Rittig

Jens Bauer

Natalie Köhler

Juliane S. Walz

Philip Bucher

Helmut R. Salih

Make your next move.